Ameriprise’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-2,273
Closed -$246K 3798
2020
Q1
$246K Buy
+2,273
New +$261K ﹤0.01% 3379
2017
Q4
Sell
-256,852
Closed -$23.7M 3827
2017
Q3
$23.7M Buy
256,852
+114,886
+81% +$11M 0.01% 941
2017
Q2
$16.1M Sell
141,966
-79,792
-36% -$8.92M 0.01% 1182
2017
Q1
$22.2M Buy
221,758
+46,881
+27% +$5.01M 0.01% 946
2016
Q4
$18.8M Sell
174,877
-18,295
-9% -$2.14M 0.01% 1038
2016
Q3
$24M Buy
193,172
+3,331
+2% +$393K 0.01% 826
2016
Q2
$20.2M Buy
189,841
+138,020
+266% +$16M 0.01% 900
2016
Q1
$5.93M Buy
51,821
+17,380
+50% +$2.04M ﹤0.01% 1825
2015
Q4
$4.91M Sell
34,441
-261,246
-88% -$30.2M ﹤0.01% 2032
2015
Q3
$26.6M Buy
295,687
+145,637
+97% +$15.4M 0.02% 759
2015
Q2
$17.3M Buy
150,050
+94,009
+168% +$9.88M 0.01% 1124
2015
Q1
$5.35M Sell
56,041
-6,875
-11% -$514K ﹤0.01% 2069
2014
Q4
$4.23M Sell
62,916
-8,023
-11% -$497K ﹤0.01% 2156
2014
Q3
$3.83M Buy
70,939
+10,939
+18% +$538K ﹤0.01% 2192
2014
Q2
$2.67M Buy
+60,000
New +$2.45M ﹤0.01% 2410

Other funds holding CBPO

Ameriprise's CBPO Position: Q2 2020 in Review

Ameriprise sold out of China Biologic Products Holdings, Inc. (CBPO) in Q2 2020, closing a stake of 2,273 shares — an estimated $246K sold.

Ameriprise first reported a position in CBPO in Q2 2014 and held it in 15 quarters. The position peaked at $26.6M in Q3 2015. 91 funds tracked by Wall St. Rank hold CBPO as of Q2 2020.

  • Ameriprise reported no remaining China Biologic Products Holdings, Inc. position as of Q2 2020 after selling out during the quarter.
  • Ameriprise sold 2,273 China Biologic Products Holdings, Inc. shares in Q2 2020, an estimated $246K.
  • Ameriprise first reported a position in China Biologic Products Holdings, Inc. in Q2 2014 and held it in 15 quarters.
  • Ameriprise's China Biologic Products Holdings, Inc. position peaked at $26.6M in Q3 2015.
  • 91 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q2 2020.

Based on Ameriprise's 13F filing for Q2 2020, filed 14 Aug 2020.